Liver cancer cells: Targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres

Engineering & Materials Science

• Silica nanoparticles 100%
• Alginate 96%
• Microspheres 87%
• Liver 79%
• Cells 64%
• Drug Delivery Systems 26%
• Arginine 21%
• Biocompatibility 14%
• Amino acids 14%
• Acids 10%
• Cytotoxicity 8%
• Drug delivery 8%
• Peptides 7%
• Assays 7%
• Atomization 6%
• Microscopic examination 6%
• Scanning 4%
• Lasers 4%
• Air 3%

Medicine & Life Sciences

• Drug Carriers 79%
• Alginates 76%
• Silicon Dioxide 75%
• Microspheres 67%
• Liver Neoplasms 66%
• Nanoparticles 58%
• rhodamine 6G 20%
• Drug Delivery Systems 17%
• Aspartic Acid 12%
• Glycine 12%
• Doxorubicin 11%
• Arginine 11%
• Pharmaceutical Preparations 9%
• thiazolyl blue 7%
• Drug Liberation 5%
• Lysine 5%
• Confocal Microscopy 5%
• Tyrosine 5%
• Hepatocellular Carcinoma 4%
• Air 4%
• Peptides 3%
• Therapeutics 0%

Chemical Compounds

• Drug Carrier 70%
• Alginate 67%
• Microsphere 56%
• Nanoparticle 33%
• Drug 12%
• Drug Vehicle 9%
• 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide 7%
• Rhodamine 6G 7%
• Confocal Laser Scanning Microscopy 7%
• Doxorubicin 6%
• Lysine 5%
• Acid 4%
• Surface Area 3%
• Peptide 3%
• Surface 1%